Deguchi, S.; Otake, H.; Nakazawa, Y.; Hiramatsu, N.; Yamamoto, N.; Nagai, N.
Ophthalmic Formulation Containing Nilvadipine Nanoparticles Prevents Retinal Dysfunction in Rats Injected with Streptozotocin. Int. J. Mol. Sci. 2017, 18, 2720.
https://doi.org/10.3390/ijms18122720
AMA Style
Deguchi S, Otake H, Nakazawa Y, Hiramatsu N, Yamamoto N, Nagai N.
Ophthalmic Formulation Containing Nilvadipine Nanoparticles Prevents Retinal Dysfunction in Rats Injected with Streptozotocin. International Journal of Molecular Sciences. 2017; 18(12):2720.
https://doi.org/10.3390/ijms18122720
Chicago/Turabian Style
Deguchi, Saori, Hiroko Otake, Yosuke Nakazawa, Noriko Hiramatsu, Naoki Yamamoto, and Noriaki Nagai.
2017. "Ophthalmic Formulation Containing Nilvadipine Nanoparticles Prevents Retinal Dysfunction in Rats Injected with Streptozotocin" International Journal of Molecular Sciences 18, no. 12: 2720.
https://doi.org/10.3390/ijms18122720
APA Style
Deguchi, S., Otake, H., Nakazawa, Y., Hiramatsu, N., Yamamoto, N., & Nagai, N.
(2017). Ophthalmic Formulation Containing Nilvadipine Nanoparticles Prevents Retinal Dysfunction in Rats Injected with Streptozotocin. International Journal of Molecular Sciences, 18(12), 2720.
https://doi.org/10.3390/ijms18122720